Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas

Clinical trial NCT05182164 · RECRUITING

Trial details

NCT number: NCT05182164
Sponsor: Institut Bergonié
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Soft Tissue Sarcoma Adult Advanced Soft-tissue Sarcoma Ewing Sarcoma Osteosarcoma Undifferentiated Pleomorphic Sarcoma

Start date: 2022-04-25
Primary completion: 2026-12-01
Enrollment: 119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.